Cadre Bioscience, LLC
St. Louis, MO
- UEI
- HVSVM481KUF9
- CAGE
- 8GX25
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 4340 Duncan Ave #239, St. Louis, MO 63110, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a novel approach to immunotherapy. | National Cancer Institute (NIH) | $706,822 | |
| Estrogen-related receptor agonists for the treatment of heart failure. | National Heart Lung and Blood Institute (NIH) | $1,292,565 |
Quick answers
Is Cadre Bioscience, LLC registered in SAM.gov?
Yes. Cadre Bioscience, LLC's SAM.gov registration is active through July 16, 2027.
What is Cadre Bioscience, LLC's most recent federal award?
Cadre Bioscience, LLC's most recent federal grant award is Development of a novel approach to immunotherapy (R43CA281404), from National Cancer Institute (NIH), on April 1, 2023.
On GovTribe
See Cadre Bioscience, LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors